About Flexion: At Flexion, were building the intelligence layer powering the next generation of humanoid robots. Our mission is to accelerate the transition from fragile prototypes to real-world humanoid deployment. We are founded by leading scientists
Gravis Robotics is a high-growth Series A start-up backed by SoftBank, bringing Physical AI to the construction industry, turning heavy construction machines into autonomous robots. Gravis began as an ETH Zurich spin-out, and our unique combination
CSL Vifor is seeking a Director Non-Clinical Due Diligence & External Evaluations to lead scientific assessment of nonclinical data supporting in-licensing, acquisitions, and collaborations. You will integrate toxicology, PK/QSP, and pharmacology inputs to identify risks and
The Director Non-Clinical Due Diligence & External Evaluations providesscientific leadership for nonclinical due diligencesupporting CSL’s in-licensing, acquisitions, and strategic collaborations. The role ensuresintegrated, objective, and decision-relevant evaluationsof nonclinical pharmacology, PK/QSP, and toxicology data to identify development